Table 2. Main clinical features of the women in the AE and MLD groups.
AE | MLD | p-value | |||
---|---|---|---|---|---|
n | % | N | % | ||
Age | 0.84 | ||||
<55 years | 22 | 41.5 | 24 | 45.3 | |
≥55 years | 31 | 58.5 | 29 | 54.7 | |
Body Mass Index | 0.53 | ||||
<25 Kg/m2 | 15 | 28.3 | 19 | 35.8 | |
≥25 Kg/m2 | 38 | 71.7 | 34 | 64.2 | |
Type of Surgery | 0.0786* | ||||
MRM Patey | 29 | 54.7 | 19 | 35.8 | |
MRM Madden | 24 | 45.3 | 33 | 62.3 | |
RM Halsted | 0 | 0.0 | 1 | 1.9 | |
Operated breast | 0.8455 | ||||
Right | 29 | 54.7 | 28 | 52.8 | |
Left | 24 | 45.3 | 25 | 47.2 | |
Dominant limb | 1.0000* | ||||
Right | 49 | 92.2 | 50 | 94.3 | |
Left | 4 | 7.5 | 3 | 5.7 | |
Clinical Stage | 0.0705* | ||||
I | 1 | 2.0 | 0 | 0.0 | |
II | 17 | 34.0 | 9 | 18.0 | |
III/IV | 32 | 64.0 | 43 | 82.0 | |
Surgical Stage | 0.0915* | ||||
I | 2 | 3.8 | 1 | 1.9 | |
II | 20 | 37.7 | 11 | 20.8 | |
III/IV | 31 | 58.5 | 41 | 77.4 | |
Level of dissected lymph nodes | 0.2703* | ||||
1 | 2 | 3.8 | 0 | 0.0 | |
2 or 3 | 51 | 96.3 | 53 | 100.0 | |
Neoadjuvant chemotherapy | 0.0187 | ||||
Yes | 24 | 45.3 | 36 | 67.9 | |
No | 29 | 54.7 | 17 | 32.1 | |
Adjuvant chemotherapy | 0.0690 | ||||
Yes | 8 | 36.4 | 18 | 62.1 | |
No | 14 | 63.6 | 11 | 37.9 | |
Radiotherapy | 0.2901* | ||||
Yes | 16 | 72.7 | 26 | 86.7 | |
No | 6 | 27.3 | 4 | 13.3 | |
Irradiation | 0.1783* | ||||
Plastron | 1 | 6.3 | 6 | 23.1 | |
Plastron+SCF | 14 | 87.5 | 18 | 69.2 | |
Plastron+SCF+Axilla | 0 | 0.0 | 2 | 7.7 | |
Plastron+SCF+Cervical region | 1 | 6.3 | 0 | 0.0 | |
Hormone therapy | 0.790* | ||||
Yes | 14 | 63.6 | 18 | 60.0 | |
No | 8 | 36.4 | 12 | 40.0 | |
Immunotherapy | 1.000* | ||||
Yes | 3 | 13.6 | 5 | 16.7 | |
No | 19 | 86.4 | 25 | 83.3 | |
Shoulderhistory antecedentes | 0.449* | ||||
Fracture | 1 | 1.9 | 5 | 9.6 | |
Luxation | 1 | 1.9 | 0 | 0.0 | |
Bursitis | 2 | 3.8 | 2 | 3.8 | |
Tendinitis | 5 | 9.6 | 5 | 9.6 | |
Unknown pain | 6 | 11.5 | 9 | 17.3 | |
Absent | 37 | 71.2 | 31 | 59.6 | |
Heaviness sensation | 0.3757 | ||||
Yes | 9 | 36.0 | 16 | 64.0 | |
No | 13 | 48.1 | 14 | 51.9 | |
Smoking | 1.0000* | ||||
Yes | 2 | 40.0 | 3 | 60.0 | |
No | 20 | 42.5 | 27 | 57.5 | |
Practice of exercises | 0.4575 | ||||
Yes | 8 | 36.4 | 14 | 63.6 | |
No | 14 | 46.7 | 16 | 53.3 | |
Care UL | 0.3481* | ||||
Follows daily | 15 | 68.2 | 17 | 56.7 | |
Follows partly | 5 | 22.7 | 12 | 40.0 | |
No follows | 2 | 9.1 | 1 | 3.3 | |
Seroma | 0.2201 | ||||
Yes | 16 | 40.0 | 24 | 60.0 | |
No | 33 | 52.4 | 30 | 47.6 | |
Aspiration | 0.1114 | ||||
Yes | 13 | 37.1 | 22 | 62.9 | |
No | 36 | 53.7 | 31 | 46.3 | |
Dehiscence | 0.8280 | ||||
Yes | 6 | 50.0 | 6 | 50.0 | |
No | 42 | 46.7 | 48 | 53.3 | |
Infection | 0.2723 | ||||
Yes | 15 | 55.6 | 12 | 44.4 | |
No | 32 | 43.2 | 42 | 56.8 |
MRM = modified radical mastectomy; RM = radical mastectomy; SCF = supraclavicular fossa; UL = upper limbs/ Chi-Square test;
(*) Fisher’s Exact test